Skip to main content

Pemphigus Vulgaris

  • Chapter
  • First Online:
Life-Threatening Rashes
  • 896 Accesses

Abstract

Pemphigus vulgaris is associated with high mortality if not treated. The classic clinical course is painful mucosal blisters and skin erosions. Mucosal lesions most commonly occur in the mouth, but any mucosal surface may be involved. Cutaneous blisters and bullae usually occur after mucosal lesions form, are typically painful and not pruritic, and are associated with positive Nikolsky sign. Fever is atypical and suggests superinfection. Diagnosis is clinical in the emergency department but can be confirmed with biopsy. Extensive lesions, severe superinfection, and toxic appearance require admission. Management includes systemic glucocorticoids, oral care, skin care, and adjunctive treatments as needed to facilitate resolution of lesions. Complications include electrolyte disorders, hypovolemia, secondary infection, and medication side effects. Superinfection can result in severe morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006;355:1800.

    Article  CAS  PubMed  Google Scholar 

  2. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11:462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: clinical manifestations. J Dtsch Dermatol Ges. 2011;9:844.

    PubMed  Google Scholar 

  4. Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366:61.

    Article  PubMed  Google Scholar 

  5. Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Dermatol Clin. 2011;29:373.

    Article  CAS  PubMed  Google Scholar 

  6. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol. 2005;14:861.

    Article  CAS  PubMed  Google Scholar 

  7. Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2012;45:7.

    Article  CAS  PubMed  Google Scholar 

  8. Amagai M, Tsunoda K, Zillikens D, et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol. 1999;40:167.

    Article  CAS  PubMed  Google Scholar 

  9. Ding X, Aoki V, Mascaro JM Jr, et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol. 1997;109:592.

    Article  CAS  PubMed  Google Scholar 

  10. Firooz A, Mazhar A, Ahmed AR. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol. 1994;31:434.

    Article  CAS  PubMed  Google Scholar 

  11. Brenner S, Goldberg I. Drug-induced pemphigus. Clin Dermatol. 2011;29:455.

    Article  PubMed  Google Scholar 

  12. Ruocco V, Pisani M. Induced pemphigus. Arch Dermatol Res. 1982;274:123.

    Article  CAS  PubMed  Google Scholar 

  13. Ruocco V, Ruocco E, Lo Schiavo A, et al. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31:374.

    Article  PubMed  Google Scholar 

  14. Brenner S, Tur E, Shapiro J, et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol. 2001;40:562.

    Article  CAS  PubMed  Google Scholar 

  15. Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011;29:432.

    Article  PubMed  Google Scholar 

  16. James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011;29:405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Brenner S, Wohl Y. A survey of sex differences in 249 pemphigus patients and possible explanations. Skinmed. 2007;6:163.

    Article  PubMed  Google Scholar 

  18. Diaz LA, Sampaio SA, Rivitti EA, et al. Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol. 1989;92:4.

    Article  CAS  PubMed  Google Scholar 

  19. Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015;14:930.

    Article  PubMed  Google Scholar 

  20. Kavala M, TopaloÄŸlu Demir F, Zindanci I, et al. Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal pap smear findings. J Am Acad Dermatol. 2015;73:655.

    Article  PubMed  Google Scholar 

  21. Kavala M, Altıntaş S, Kocatürk E, et al. Ear, nose and throat involvement in patients with pemphigus vulgaris: correlation with severity, phenotype and disease activity. J Eur Acad Dermatol Venereol. 2011;25:1324.

    Article  CAS  PubMed  Google Scholar 

  22. Torchia D, Romanelli P, Kerdel FA. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus. J Am Acad Dermatol. 2012;67:417.

    Article  PubMed  Google Scholar 

  23. Amagai M. Pemphigus. In: Bolognia JL, Jorizzo JL, Schaffer JV, et al., editors. Dermatology, 3rd ed. vol 1. Elsevier, Saunders; 2012. p. 2776. ISBN: 9780702051821.

    Google Scholar 

  24. Shinkuma S, Nishie W, Shibaki A, et al. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature. Clin Exp Dermatol. 2008;33:724.

    Article  CAS  PubMed  Google Scholar 

  25. Payne AS, Stanley JR. Pemphigus. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine, vol. 1. 8th ed. New York: McGraw Hill; 2012. https://accessmedicine.mhmedical.com/content.aspx?bookid=392&sectionid=41138687. Accessed January 14, 2018.

  26. Lebeau S, Müller R, Masouyé I, et al. Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. Clin Exp Dermatol. 2010;35:366.

    Article  CAS  PubMed  Google Scholar 

  27. Martin LK, Werth V, Villanueva E, et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev. 2009;(1):CD006263.

    Google Scholar 

  28. Beissert S, Werfel T, Frieling U, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142:1447.

    Article  CAS  PubMed  Google Scholar 

  29. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132:203.

    Article  CAS  PubMed  Google Scholar 

  30. Kasperkiewicz M, Schmidt E, Zillikens D. Current therapy of the pemphigus group. Clin Dermatol. 2012;30:84.

    Article  PubMed  Google Scholar 

  31. Atzmony L, Hodak E, Leshem YA, et al. The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73:264.

    Article  PubMed  Google Scholar 

  32. Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolone regimens. A 5-year study. Int J Dermatol. 1990;29:363.

    Article  CAS  PubMed  Google Scholar 

  33. Harman KE, Albert S, Black MM, British Association of Dermatologists. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149:926.

    Article  CAS  PubMed  Google Scholar 

  34. Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58:1043.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J Dtsch Dermatol Ges. 2011;9:927.

    PubMed  Google Scholar 

  36. Hertl M. Pemphigus vulgaris. CME Dermatol. 2009;4:94.

    Google Scholar 

  37. Caldarola G, Kneisel A, Hertl M, Feliciani C. Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations. Eur J Dermatol. 2008;18:440.

    PubMed  Google Scholar 

Download references

Acknowledgments

The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of Brooke Army Medical Center, the US Army Medical Department, the US Army Office of the Surgeon General, the US Department of the Air Force, the US Department of the Army or the Department of Defense, or the US Government.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Long, B., Koyfman, A. (2018). Pemphigus Vulgaris. In: Rose, E. (eds) Life-Threatening Rashes. Springer, Cham. https://doi.org/10.1007/978-3-319-75623-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-75623-3_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-75622-6

  • Online ISBN: 978-3-319-75623-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics